Exclusion Criteria:~* Any medical or neurological conditions other than AD that could explain the patient's
dementia~* A current diagnosis of probable or possible vascular dementia~* A score of > 5 on the Modified
Hachinski Ischemic Scale (MHIS)~* A current DSM-IV Axis 1 diagnosis that may interfere with the evaluation of
the patient's response to study medication.~* Treated with donepezil or galantamine within last 4 weeks before
the efficacy assessment at baseline.~* an advanced severe progressive or unstable disease of any type that may
interfere with efficacy and safety assessments or put the patient's at special risk~* Other protocol-defined
inclusion/exclusion criteria may apply.
